Back to top
more

Ingevity (NGVT)

(Delayed Data from NYSE)

$40.40 USD

40.40
333,965

-1.39 (-3.33%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $40.40 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (167 out of 246)

Industry: Chemical - Specialty

Zacks News

Zacks Equity Research

ArcelorMittal's Q4 Earnings Beat Estimates, Revenues Miss

MT's Q4 sales are affected by a decline in average steel selling prices.

Zacks Equity Research

LyondellBasell Inks Agreements as a Step Toward Energy Transition

LYB signs agreements with Vattenfall and wpd to stabilize energy costs.

Zacks Equity Research

Air Products' Earnings Meet Estimates, Revenues Miss in Q1

The decline of APD's Q1 sales is attributable to lower volumes and adverse currency that largely offset increased prices.

Zacks Equity Research

ATI's Earnings and Revenues Beat Estimates in Q4, Sales Up Y/Y

ATI's earnings and revenues beat estimates in the fourth quarter while also outperforming in the segment-wise results.

Zacks Equity Research

Axalta's Earnings and Revenues Surpass Estimates in Q4, Up Y/Y

AXTA gains on the contribution from the CoverFlexx acquisition amid currency headwinds in Q4.

Zacks Equity Research

FMC Corp's Earnings Surpass Estimates, Revenues Miss in Q4

FMC's Q4 revenues are driven by a 15% increase in volume, with growth reported in several countries, especially the United States.

Zacks Equity Research

Cabot's Earnings and Revenues Lag Estimates in Q1, EPS Up Y/Y

Cabot misses Q1 earnings and revenue estimates but demonstrates better results in EBIT and adjusted EPS metrics.

Zacks Equity Research

Hawkins' Earnings Lag, Revenues Surpass Estimates in Q3

HWKN's Water Treatment unit benefits from added sales from acquired businesses and higher sales volumes in the legacy business in Q3.

Zacks Equity Research

Olin's Q4 Earnings and Revenues Beat Estimates, Sales Up Y/Y

OLN beats estimates, driven by higher volumes and selling prices in Chlor Alkali Products and Vinyls and the strong performance of the Winchester unit.

Zacks Equity Research

Scotts Miracle-Gro's Q1 Earnings and Revenues Beat Estimates

SMG sees a double-digit increase in U.S. Consumer division sales in Q1, offset by a decline in the Hawthorne unit.

Zacks Equity Research

Eastman Chemical's Q4 Earnings Beat Estimates, Sales Lag

EMN's Q4 earnings beat estimates driven by higher sales/volume mix and selling prices.

Zacks Equity Research

LyondellBasell's Q4 Earnings Meet, Revenues Beat Estimates

LYB's businesses delivers strong cash performance amid difficult market conditions in Q4.

Zacks Equity Research

U.S. Steel's Earnings and Revenues Beat Estimates in Q4

X sees lower pricing and demand environment across all its segments in the fourth quarter.

Zacks Equity Research

PPG Industries Misses Earnings and Sales Estimates in Q4

Adjusted EPS and total segment EBITDA margins of PPG increase in Q4 due to sales of technology-advantaged products.

Zacks Equity Research

Dow's Q4 Earnings and Revenues Miss Estimates on Lower Prices

DOW faces headwinds from continued soft macroeconomic conditions and weaker prices, which weighed on its Q4 performance.

Zacks Equity Research

Methanex's Q4 Earnings Outpace Estimates, Revenues Miss

MEOH earnings beat estimates in the fourth quarter on higher average realized prices.

Zacks Equity Research

Sherwin-Williams Q4 Earnings Beat Estimates, Revenues Lag

Consolidated net sales of SHW rise owing to higher sales in the Paint Stores Group in Q4.

Zacks Equity Research

Ashland's Earnings Outpace Estimates, Revenues Miss in Q1

Organic sales volume growth in ASH's Personal Care, Specialty Additives and Intermediates segments largely offset lower volumes in Life Sciences in Q1.

Zacks Equity Research

Barrick Gold's Kibali Mine Gives a Strong Performance in Q4

GOLD's Kibali has recorded a high performance in the last quarter of 2024, building the foundation for strong results in 2025 and beyond.

Zacks Equity Research

Is Ingevity (NGVT) Outperforming Other Basic Materials Stocks This Year?

Here is how Ingevity (NGVT) and Nouveau Monde Graphite Inc. (NMG) have performed compared to their sector so far this year.

Zacks Equity Research

Nucor's Earnings and Revenues Surpass Estimates in Q4, Down Y/Y

NUE's earnings for the fourth quarter decline primarily due to lower prices.

Zacks Equity Research

Newmont to Divest its Porcupine Operation for up to $425 Million

The agreement to sell Porcupine Operation for $425 million marks the final transaction of NEM's divestiture program.

Zacks Equity Research

Barrick's Lumwana Among Top Contributors to Zambia's Economic Growth

GOLD contributes highly to Zambia's economic growth and the advancement of local content in Zambia.

Zacks Equity Research

Axalta and Durr Team Up to Provide Digital Paint Solution

AXTA enters into a strategic partnership with Durr Systems AG to introduce overspray-free applications in the market.

Zacks Equity Research

Zacks.com featured highlights include Harmony Biosciences, Ingevity, Gulfport Energy and Pitney Bowes

Harmony Biosciences, Ingevity, Gulfport Energy and Pitney Bowes have been highlighted in this Screen of The Week article.